{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:05:45Z","timestamp":1793379945925,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32330058"],"award-info":[{"award-number":["32330058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204303"],"award-info":[{"award-number":["82204303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82125035"],"award-info":[{"award-number":["82125035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Education Commission Major Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75413-x","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:03:57Z","timestamp":1783523037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary mRNA-LNP vaccines for rapid and durable protection against bacterial infection"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5915-2131","authenticated-orcid":false,"given":"Anqi","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4953-2785","authenticated-orcid":false,"given":"Dexuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuansong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0511-6817","authenticated-orcid":false,"given":"Zui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-2829","authenticated-orcid":false,"given":"Changyou","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7652-4474","authenticated-orcid":false,"given":"Xiaoli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"75413_CR1","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"KS Ikuta","year":"2022","unstructured":"Ikuta, K. S. et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.  Lancet 400, 2221\u20132248 (2022).","journal-title":"Lancet"},{"key":"75413_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2478\/jtim-2018-0006","volume":"6","author":"YG Zhu","year":"2018","unstructured":"Zhu, Y. G., Tang, X. D., Lu, Y. T., Zhang, J. & Qu, J. M. Contemporary situation of community-acquired pneumonia in China: a systematic review. J. Transl. Int. Med. 6, 26\u201331 (2018).","journal-title":"J. Transl. Int. Med."},{"key":"75413_CR3","doi-asserted-by":"publisher","first-page":"e2314185","DOI":"10.1001\/jamanetworkopen.2023.14185","volume":"6","author":"BE Jones","year":"2023","unstructured":"Jones, B. E. et al. Incidence and outcomes of non-ventilator-associated hospital-acquired pneumonia in 284 US hospitals using electronic surveillance criteria. JAMA Netw. Open 6, e2314185\u2013e2314185 (2023).","journal-title":"JAMA Netw. Open"},{"key":"75413_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ajic.2022.06.016","volume":"51","author":"KK Giuliano","year":"2023","unstructured":"Giuliano, K. K. et al. Incidence, mortality, and cost trends in nonventilator hospital-acquired pneumonia in medicaid beneficiaries, 2015-2019. Am. J. Infect. Control 51, 227\u2013230 (2023).","journal-title":"Am. J. Infect. Control"},{"key":"75413_CR5","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","volume":"370","author":"SS Magill","year":"2014","unstructured":"Magill, S. S. et al. Multistate point-prevalence survey of health care-associated infections. N. Engl. J. Med. 370, 1198\u20131208 (2014).","journal-title":"N. Engl. J. Med."},{"key":"75413_CR6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050.  Lancet 404, 1199\u20131226 (2024).","journal-title":"Lancet"},{"key":"75413_CR7","volume":"43","author":"C Zhang","year":"2024","unstructured":"Zhang, C., Fu, X., Liu, Y., Zhao, H. & Wang, G. Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019. Lancet Reg. Health West Pac. 43, 100972 (2024).","journal-title":"Lancet Reg. Health West Pac."},{"key":"75413_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/INF.0000000000004300","volume":"43","author":"P Korbal","year":"2024","unstructured":"Korbal, P. et al. Phase 3 safety and immunogenicity study of a three-dose series of twenty-valent pneumococcal conjugate vaccine in healthy infants and toddlers. Pediatr. Infect. Dis. J. 43, 587\u2013595 (2024).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"75413_CR9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/cid\/ciab990","volume":"75","author":"B Essink","year":"2022","unstructured":"Essink, B. et al. Pivotal phase 3 randomized clinical trial of the safety, tolerability, and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults aged \u226518 years. Clin. Infect. Dis. 75, 390\u2013398 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"75413_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100429","volume":"19","author":"E Molteni","year":"2022","unstructured":"Molteni, E. et al. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: a prospective longitudinal cohort study.  Lancet Reg. Health - Eur. 19, 100429 (2022).","journal-title":"Lancet Reg. Health - Eur."},{"key":"75413_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41423-023-01095-w","volume":"21","author":"D Lapuente","year":"2024","unstructured":"Lapuente, D., Winkler, T. H. & Tenbusch, M. B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity. Cell. Mol. Immunol. 21, 144\u2013158 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"75413_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41578-021-00372-2","volume":"7","author":"GA Roth","year":"2022","unstructured":"Roth, G. A. et al. Designing spatial and temporal control of vaccine responses. Nat. Rev. Mater. 7, 174\u2013195 (2022).","journal-title":"Nat. Rev. Mater."},{"key":"75413_CR13","doi-asserted-by":"crossref","unstructured":"Cruz-L\u00f3pez, F., Mart\u00ednez-Mel\u00e9ndez, A. & Garza-Gonz\u00e1lez, E. How does hospital microbiota contribute to healthcare-associated infections? Microorganisms 11, 192 (2023).","DOI":"10.3390\/microorganisms11010192"},{"key":"75413_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25120-6","volume":"12","author":"Z-J Li","year":"2021","unstructured":"Li, Z.-J. et al. Etiological and epidemiological features of acute respiratory infections in China. Nat. Commun. 12, 5026 (2021).","journal-title":"Nat. Commun."},{"key":"75413_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R. & Anderson, D. G. The clinical progress of mRNA vaccines and immunotherapies. Nat. Biotechnol. 40, 840\u2013854 (2022).","journal-title":"Nat. Biotechnol."},{"key":"75413_CR16","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"75413_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"C Hald Albertsen","year":"2022","unstructured":"Hald Albertsen, C. et al. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv. Drug Deliv. Rev. 188, 114416 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"75413_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.immuni.2016.09.011","volume":"45","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. et al. Structural analysis reveals that toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA. Immunity 45, 737\u2013748 (2016).","journal-title":"Immunity"},{"key":"75413_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines\u2014a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261\u2013279 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"75413_CR20","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","volume":"54","author":"MG Alameh","year":"2021","unstructured":"Alameh, M. G. et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity 54, 2877\u20132892.e2877 (2021).","journal-title":"Immunity"},{"key":"75413_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","volume":"15","author":"KJ Hassett","year":"2019","unstructured":"Hassett, K. J. et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol. Ther. Nucleic Acids 15, 1\u201311 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"75413_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53914-x","volume":"15","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination. Nat. Commun. 15, 9471 (2024).","journal-title":"Nat. Commun."},{"key":"75413_CR23","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1080\/17425247.2022.2131767","volume":"19","author":"EM Jansen","year":"2022","unstructured":"Jansen, E. M., Frijlink, H. W., Hinrichs, W. L. & Ruigrok, M. J. Are inhaled mRNA vaccines safe and effective? A review of preclinical studies. Expert Opin. Drug Deliv. 19, 1471\u20131485 (2022).","journal-title":"Expert Opin. Drug Deliv."},{"key":"75413_CR24","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.matt.2022.06.012","volume":"5","author":"KD Popowski","year":"2022","unstructured":"Popowski, K. D. et al. Inhalable dry powder mRNA vaccines based on extracellular vesicles. Matter 5, 2960\u20132974 (2022).","journal-title":"Matter"},{"key":"75413_CR25","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","volume":"55","author":"RC Mettelman","year":"2022","unstructured":"Mettelman, R. C., Allen, E. K. & Thomas, P. G. Mucosal immune responses to infection and vaccination in the respiratory tract. Immunity 55, 749\u2013780 (2022).","journal-title":"Immunity"},{"key":"75413_CR26","doi-asserted-by":"publisher","first-page":"204ra130","DOI":"10.1126\/scitranslmed.3006516","volume":"5","author":"AV Li","year":"2013","unstructured":"Li, A. V. et al. Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Sci. Transl. Med. 5, 204ra130 (2013).","journal-title":"Sci. Transl. Med."},{"key":"75413_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41565-023-01548-3","volume":"19","author":"AY Jiang","year":"2024","unstructured":"Jiang, A. Y. et al. Combinatorial development of nebulized mRNA delivery formulations for the lungs. Nat. Nanotechnol. 19, 364\u2013375 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"75413_CR28","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41587-023-01679-x","volume":"41","author":"B Li","year":"2023","unstructured":"Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410\u20131415 (2023).","journal-title":"Nat. Biotechnol."},{"key":"75413_CR29","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"75413_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","volume":"18","author":"X Han","year":"2023","unstructured":"Han, X. et al. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat. Nanotechnol. 18, 1105\u20131114 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"75413_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32560-1","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu, H., Lau, V. H. M., Xu, P., Chan, T. H. & Huang, Z. Diverse synthesis of \u03b1-tertiary amines and tertiary alcohols via desymmetric reduction of malonic esters. Nat. Commun. 13, 4759 (2022).","journal-title":"Nat. Commun."},{"key":"75413_CR32","doi-asserted-by":"publisher","first-page":"34304","DOI":"10.1021\/jacs.4c14669","volume":"146","author":"K Devi","year":"2024","unstructured":"Devi, K., Shehzad, A. & Wiesenfeldt, M. P. Organophotocatalytic reduction of benzenes to cyclohexenes. J. Am. Chem. Soc. 146, 34304\u201334310 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"75413_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"75413_CR34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrmicro2199","volume":"7","author":"AR Hauser","year":"2009","unstructured":"Hauser, A. R. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7, 654\u2013665 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"75413_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue, R. et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature 612, 141\u2013147 (2022).","journal-title":"Nature"},{"key":"75413_CR36","doi-asserted-by":"crossref","unstructured":"Yang, L. et al. Extracellular matrix anchored neutrophils drive pulmonary fibrosis in mice. Nat. Commun. 16, 11655 (2025).","DOI":"10.1038\/s41467-025-66633-8"},{"key":"75413_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34064-4","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion. Nat. Commun. 13, 6308 (2022).","journal-title":"Nat. Commun."},{"key":"75413_CR38","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/nm.3258","volume":"19","author":"CS Robbins","year":"2013","unstructured":"Robbins, C. S. et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19, 1166\u20131172 (2013).","journal-title":"Nat. Med."},{"key":"75413_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/sj.cr.7310017","volume":"16","author":"Y Shi","year":"2006","unstructured":"Shi, Y. et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don\u2019t know. Cell Res. 16, 126\u2013133 (2006).","journal-title":"Cell Res."},{"key":"75413_CR40","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1182\/blood-2013-02-486217","volume":"121","author":"K De Filippo","year":"2013","unstructured":"De Filippo, K. et al. Mast cell and macrophage chemokines CXCL1\/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121, 4930\u20134937 (2013).","journal-title":"Blood"},{"key":"75413_CR41","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/JLB.3MR0621-616RR","volume":"111","author":"Y-D Xu","year":"2022","unstructured":"Xu, Y.-D., Cheng, M., Shang, P.-P. & Yang, Y.-Q. Role of IL-6 in dendritic cell functions. J. Leukoc. Biol. 111, 695\u2013709 (2022).","journal-title":"J. Leukoc. Biol."},{"key":"75413_CR42","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833\u20131840 (2008).","journal-title":"Mol. Ther."},{"key":"75413_CR43","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1016\/j.cell.2025.11.023","volume":"188","author":"D Casta\u00f1o","year":"2025","unstructured":"Casta\u00f1o, D. et al. Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses. Cell 188, 7461\u20137480.e7423 (2025).","journal-title":"Cell"},{"key":"75413_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107771","volume":"300","author":"O Babadei","year":"2024","unstructured":"Babadei, O., Strobl, B., M\u00fcller, M. & Decker, T. Transcriptional control of interferon-stimulated genes. J. Biol. Chem. 300, 107771 (2024).","journal-title":"J. Biol. Chem."},{"key":"75413_CR45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","volume":"1","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W. & Rice, C. M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1, 519\u2013525 (2011).","journal-title":"Curr. Opin. Virol."},{"key":"75413_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/mtm.2014.5","volume":"1","author":"D Damjanovic","year":"2014","unstructured":"Damjanovic, D. et al. Type 1 interferon gene transfer enhances host defense against pulmonary Streptococcus pneumoniae infection via activating innate leukocytes. Mol. Ther. Methods Clin. Dev. 1, 5 (2014).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"75413_CR47","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.chom.2016.05.016","volume":"19","author":"GM Boxx","year":"2016","unstructured":"Boxx, G. M. & Cheng, G. The roles of type I interferon in bacterial infection. Cell Host Microbe 19, 760\u2013769 (2016).","journal-title":"Cell Host Microbe"},{"key":"75413_CR48","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty, S. Follicular Helper CD4 T Cells (TFH). Annu. Rev. Immunol. 29, 621\u2013663 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"75413_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal Centers. Annu. Rev. Immunol. 30, 429\u2013457 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"75413_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00672-4","volume":"8","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa. npj Vaccines 8, 76 (2023).","journal-title":"npj Vaccines"},{"key":"75413_CR51","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1128\/IAI.00533-16","volume":"84","author":"A Vogelzang","year":"2016","unstructured":"Vogelzang, A. et al. Neonatal Fc receptor regulation of lung immunoglobulin and CD103+ dendritic cells confers transient susceptibility to tuberculosis. Infect. Immun. 84, 2914\u20132921 (2016).","journal-title":"Infect. Immun."},{"key":"75413_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56302-1","volume":"16","author":"M Lin","year":"2025","unstructured":"Lin, M. et al. A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus. Nat. Commun. 16, 1386 (2025).","journal-title":"Nat. Commun."},{"key":"75413_CR53","unstructured":"Ziegenhals, T., Kuhn, A., Stephanie, F. RNA manufacturing, WO 2022\/122689 A1 (2022)."},{"key":"75413_CR54","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","volume":"29","author":"L Sikkema","year":"2023","unstructured":"Sikkema, L. et al. An integrated cell atlas of the lung in health and disease. Nat. Med. 29, 1563\u20131577 (2023).","journal-title":"Nat. Med."},{"key":"75413_CR55","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"75413_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51411-9","volume":"15","author":"S Kim","year":"2024","unstructured":"Kim, S. et al. Innate immune responses against mRNA vaccine promote cellular immunity through IFN-\u03b2 at the injection site. Nat. Commun. 15, 7226 (2024).","journal-title":"Nat. Commun."},{"key":"75413_CR57","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75413-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75413-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75413-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T22:52:46Z","timestamp":1786920766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75413-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75413"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75413-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8438"}}